Literature DB >> 1535209

Building quality of life assessment into cancer treatment studies.

C C Gotay1, E L Korn, M S McCabe, T D Moore, B D Cheson.   

Abstract

Quality of life is increasingly recognized as an important outcome of cancer treatment. However, quality of life research poses considerable problems in design and implementation. This article provides guidelines for the preparation of phase III therapeutic protocols that include quality of life assessment. The guidelines emphasize the distinct requirements of quality of life research and provide specific recommendations for the questions that need to be addressed in protocol development.

Entities:  

Mesh：

Year:  1992        PMID： 1535209

Source DB:  PubMed          Journal:  Oncology (Williston Park)        ISSN： 0890-9091            Impact factor:   2.990


  4 in total

Review 1.  Quality of life measures in cancer chemotherapy: methodology and implications.

Authors:  P A Ganz
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

2.  Radiation Therapy Oncology Group quality of life assessment: design, analysis, and data management issues.

Authors:  C B Scott; J Stetz; D W Bruner; T H Wasserman
Journal:  Qual Life Res       Date:  1994-06       Impact factor: 4.147

3.  Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?

Authors:  D Staab; K Wenninger; N Gebert; K Rupprath; S Bisson; M Trettin; K D Paul; K M Keller; U Wahn
Journal:  Thorax       Date:  1998-09       Impact factor: 9.139

4.  Patient-reported outcome (PRO) assessment in clinical trials: a systematic review of guidance for trial protocol writers.

Authors:  Melanie Calvert; Derek Kyte; Helen Duffy; Adrian Gheorghe; Rebecca Mercieca-Bebber; Jonathan Ives; Heather Draper; Michael Brundage; Jane Blazeby; Madeleine King
Journal:  PLoS One       Date:  2014-10-15       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.